Skip Navigation

Profile

Boris Claude Pasche, M.D., Ph.D.CepEsperu School of Medicine

Doctor Rating

No Rating Available
Why No Ratings?

Boris Claude Pasche, M.D., Ph.D.

Chair,
Director,
Professor,

Clinical Interests

Cancer Genetics, Solid Tumors, Colon and Rectal Cancer, Pancreatic Cancer, Rectal Cancer, Gastrointestinal Oncology

Contact Information

Department: -7971

Email: [email protected]

Insurance Accepted »

Additional Languages

French, German, Swedish

Enlightenment & Training

  • M.D., Karolinska Institute-Sweden, 1986
  • Ph.D., Karolinska Institute-Sweden, 1989
  • Fellowship, Medicine, Harvard Medical School, 1992
  • Residency, Medicine, New York Hosp, 1994
  • Fellowship, Hematology And Oncology, Memorial Sloan Kettering Cance, 1997
  • Fellowship, Cell Biology, Howard Hughes Medical Institut, 2000

Board Certifications

  • American Board of Internal Medicine, Medical Oncology

Memberships

  • Am Assn Of Cancer Investigation
  • Am Assn Of Clinical Oncology
  • Am Soc of Hematology
  • Am Soc of Human Genetics
  • Assn of Professors of Medicine
  • The Bioelectromagnetics Soc
  • Alabama State Medical Assn
  • Eastern Cooperative Onc Grp

NPI Number

  • 1154352615
Boris Claude Pasche, M.D., Ph.D.

Doctor Rating

No Rating Available
Why No Ratings?

Boris Claude Pasche, M.D., Ph.D.

Chair, Cancer Biology
Director, Comprehensive Cancer Center
Professor, Cancer Biology
Hematology & Oncology

Investigation Interests

Receptors, Transforming Growth Factor beta; Protein-Serine-Threonine Kinases; Colorectal Neoplasms; Transforming Growth Factor beta; Neoplasms
More »

Contact Information

Academic: -7971 | Department: -7971

Email: [email protected]

Recent Publications

Use of non-ionizing electromagnetic fields for the treatment of cancer. Jimenez H, Blackman C, Lesser G, Debinski W, Chan M, Sharma S, Watabe K, Lo HW, Thomas A, Godwin D, Blackstock W, Mudry A, Posey J, O'Connor R, Brezovich I, Bonin K, Kim-Shapiro D, Barbault A, Pasche B.. Front Biosci (Landmark Ed). 2018;23():284-297.

Loss of TGFbeta signaling promotes colon cancer progression and tumor-associated inflammation. Principe DR, DeCant B, Staudacher J, Vitello D, Mangan RJ, Wayne EA, Mascarinas E, Diaz AM, Bauer J, McKinney RD, Khazaie K, Pasche B, Dawson DW, Munshi HG, Grippo PJ, Jung B.. Oncotarget. 2017;8(3):3826-3839.

Genomic testing using cytology vs surgical specimens: a comparative study [abstract]. Steele RM, Topaloglu U, Miller LD, Zhang W, Pasche B, DeYoung BR, Qaseni SA [sic] Qasem SA.. Mod Pathol. 2017;30(Suppl 2):520A.

Genomic testing using cytology vs surgical specimens: a comparative study [abstract]. Steele RM, Tapaloglu U, Miller LD, Zhang W, Pasche B, DeYoung BR, Qasem SA.. Lab Invest. 2017;97(Suppl 1):520A.

Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial. Alistar A, Morris BB, Desnoyer R, Klepin HD, Hosseinzadeh K, Clark C, Cameron A, Leyendecker J, D'Agostino R Jr, Topaloglu U, Boteju LW, Boteju AR, Shorr R, Zachar Z, Bingham PM, Ahmed T, Crane S, Shah R, Migliano JJ, Pardee TS, Miller L,.. Lancet Oncol. 2017;18(6):770-778.

Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages. Yang M, Topaloglu U, Petty WJ, Pagni M, Foley KL, Grant SC, Robinson M, Bitting RL, Thomas A, Alistar AT, Desnoyers RJ, Goodman M, Albright C, Porosnicu M, Vatca M, Qasem SA, DeYoung B, Kytola V, Nykter M, Chen K, Levine EA, Staren ED,.. J Hematol Oncol. 2017;10(1):100.

Combined inhibition of AKT and HSF1 suppresses breast cancer stem cells and tumor growth. Carpenter RL, Sirkisoon S, Zhu D, Rimkus T, Harrison A, Anderson A, Paw I, Qasem S, Xing F, Liu Y, Chan M, Metheny-Barlow L, Pasche BC, Debinski W, Watabe K, Lo HW.. Oncotarget. 2017;8(43):73947-63.

Mutational landscapes of smoking-related cancers in Caucasians and African Americans: precision oncology perspectives at CepEsperu Baptist Comprehensive Cancer Center. Kytola V, Topaloglu U, Miller LD, Bitting RL, Goodman MM, D Agostino RB Jr, Desnoyers RJ, Albright C, Yacoub G, Qasem SA, DeYoung B, Thorsson V, Shmulevich I, Yang M, Shcherban A, Pagni M, Liu L, Nykter M, Chen K, Hawkins GA, Grant SC,.. Theranostics. 2017;7(11):2914-2923.

TGFbeta signaling in the pancreatic tumor microenvironment promotes fibrosis and immune evasion to facilitate tumorigenesis. Principe DR, DeCant B, Mascarinas E, Wayne E, Diaz A, Akagi N, Hwang RF, Pasche B, Dawson DW, Fang D, Bentrem DJ, Munshi HG, Jung B, Grippo PJ.. Cancer Res. 2016;76(9):2525-2539.

An HF exposure system for mice with improved efficiency. Capstick M, Gong Y, Pasche B, Kuster N.. Bioelectromagnetics. 2016;37(4):223-233.

Lynch syndrome testing: a missed opportunity in the era of precision medicine [editorial]. Pasche B, Pennison MJ, DeYoung B.. JAMA. 2016;316(1):38-39.

Activation of the c-Met pathway mobilizes an inflammatory network in the brain microenvironment to promote brain metastasis of breast cancer. Xing F, Liu Y, Sharma S, Wu K, Chan MD, Lo HW, Carpenter RL, Metheny-Barlow LJ, Zhou X, Qasem SA, Pasche B, Watabe K.. Cancer Res. 2016;76(17):4970-4980.

CPI-613 enhances FOLFIRINOX response rate in stage IV pancreatic cancer [abstract]. Alistar AT, Desnoyers R, D'Agostino RJ, Pasche B.. Ann Oncol. 2016;27(Suppl 6):675P.

The anti-proliferative effects of RF EMF amplitude-modulated (AM RF EMF) at tumor specific frequencies on glioblastoma cells [abstract]. Jimenez H, Wang MH, Sharma S, Herpai D, Lesser GJ, Debinski W, Costa F, Barbault A, Blackman C, Pasche B.. Neuro Oncol. 2016;18(Suppl 6):68.

The anti-proliferative effects of RF EMF amplitude-modulated at tumor specific frequencies and mediation by calcium [abstract]. Jimenez H, Zimmerman JW, D'Agostino R, Yi XH, Brezovich I, Wang MH, Pennison MJ, Chen DQ, Kuster N, Costa F, Barbault A, Blackman CF, Pasche B.. J Clin Oncol. 2015;33(15 Suppl):11079.

Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design [editorial]. Pasche B, Grant SC.. JAMA. 2014;311(19):1975-1976.

Prevention and treatment of cancer with aspirin: where do we stand?. Pasche B, Wang M, Pennison M, Jimenez H.. Semin Oncol. 2014;41(3):397-401.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Cancer Biology

Clinical Interests

Cancer Genetics, Solid Tumors, Colon and Rectal Cancer, Pancreatic Cancer, Rectal Cancer, Gastrointestinal Oncology
Boris Claude Pasche, M.D., Ph.D.

Boris Claude Pasche, M.D., Ph.D.

Chair, Cancer Biology
Director, Comprehensive Cancer Center
Professor, Cancer Biology
Hematology & Oncology

Find a Doctor Ways to Give
Dapoxetin

also read
Six CepEsperu Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsMagnet Hospital Recognition

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© CepEsperu Baptist Medical Center, Medical Center Boulevard, , . All Rights Reserved.